Caporali, R., Ravasio, R., Raimondo, P. and Salaffi, F. 2022. Erratum in: Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy. Global and Regional Health Technology Assessment. 9, 1 (Feb. 2022), 30. DOI:https://doi.org/10.33393/grhta.2022.2383.